Emilio Fentanes(@Fentanes_MD) 's Twitter Profileg
Emilio Fentanes

@Fentanes_MD

Cardiologist. Interested in cardiovascular disease prevention, diagnosis and management with advanced cardiac imaging. Tweets=own opinion.

ID:754945636269633537

calendar_today18-07-2016 07:47:20

767 Tweets

409 Followers

339 Following

Follow People
Bill Pascrell, Jr. 🇺🇸🇺🇦(@BillPascrell) 's Twitter Profile Photo

If you paid a fortune at the pump this weekend, we recently voted to crack down on gas price gouging and every single republican voted no.

If you paid a fortune at the pump this weekend, we recently voted to crack down on gas price gouging and every single republican voted no.
account_circle
Ron Blankstein(@RonBlankstein) 's Twitter Profile Photo

FACT: CMSGov payment (to hospitals) for is well below the cost of providing this test

ACTION for : share with CMS how this is impacting access to patients & test availability

👏American College of Cardiology American College of Radiology Heart_SCCT for their continued joint advocacy

account_circle
Heart_SCCT(@Heart_SCCT) 's Twitter Profile Photo

How does identify patients at risk for CV events in safety sensitive occupations (eg, pilots)? (1/5)

New @heart_scct expert consensus document offers evidence based guidance Ahmad M. Slim

journalofcardiovascularct.com/article/S1934-…

How does #YesCCT identify patients at risk for CV events in safety sensitive occupations (eg, pilots)? (1/5) New @heart_scct expert consensus document offers evidence based guidance @Ahmad_M_Slim journalofcardiovascularct.com/article/S1934-…
account_circle
Ron Blankstein(@RonBlankstein) 's Twitter Profile Photo

What a treat having Juhani Knuuti talk about European Society of Cardiology CCS guideline at today's Brigham and Women’s Cardiovascular Imaging Program Grand Rounds

*PTP of obst CAD 1/3 of prior 2013 GL ; most pts <15% PTP
*Preferred test in low range: CCTA
*Preferred test in high range: Functional testing

What a treat having @JuhaniKnuuti talk about @escardio CCS guideline at today's @BWHCVImaging Grand Rounds *PTP of obst CAD 1/3 of prior 2013 GL ; most pts <15% PTP *Preferred test in low range: CCTA *Preferred test in high range: Functional testing
account_circle
Dr Andrew D. Choi(@AChoiHeart) 's Twitter Profile Photo

Was on ☎️ w insurance requiring prior authorization for a patient for nuclear stress test (clinically not suitable for CCTA) 😫

Was asked why not ? (As now 1️⃣ line in their authorization pathway for stable chest pain)

Never have I been happier to do a prior auth 👍

Was on ☎️ w insurance requiring prior authorization for a patient for nuclear stress test (clinically not suitable for CCTA) 😫 Was asked why not #YesCCT? (As now 1️⃣ line in their authorization pathway for stable chest pain) Never have I been happier to do a prior auth 👍
account_circle
Ahmad M. Slim(@Ahmad_M_Slim) 's Twitter Profile Photo

Your voice matters! a -first strategy can provide important benefits to patients. Submit comments to CMSGov by October 5 to illustrate the dramatic & detrimental effect that continued reduction in CCTA reimbursement will have on patient care. bit.ly/3c2ZZGi

account_circle
Heart_SCCT(@Heart_SCCT) 's Twitter Profile Photo

requires more labor and resources than other CTs but gets reimbursed at the same rate. Submit comments to
CMSGov by midnight ET on Monday, Oct 5 to effect change.

Find resources to write your comment at ow.ly/H4EG50BotJi

#CardiacCT requires more labor and resources than other CTs but gets reimbursed at the same rate. Submit comments to @CMSGov by midnight ET on Monday, Oct 5 to effect change. #PatientsFirst #IamAcardio #YesCCT Find resources to write your comment at ow.ly/H4EG50BotJi
account_circle
Ron Blankstein(@RonBlankstein) 's Twitter Profile Photo

Excellent and forward-thinking review led by Rhanderson Cardoso Miguel Cainzos-Achirica on use of and in individuals with diabetes -- important implications for patient management & future clinical trials

ahajournals.org/doi/10.1161/CI…

Excellent and forward-thinking review led by @RCardoso_MD @miguelcainzos23 on use of #YesCCT #CAC and #CCTA in individuals with diabetes -- important implications for patient management & future clinical trials ahajournals.org/doi/10.1161/CI…
account_circle